0.4629

12.96% 0.0531

Pre-market: .48 0.0171 +3.69%

Intensity Therapeutics Inc (INTS)

Overview News Price History Financials Why INTS Down? Discussions Forecast

Intensity Therapeutics Inc stock is traded at $0.4629, with a volume of 13.55M. It is up +12.96% in the last 24 hours and down -13.48% over the past month. Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Previous Close:

$0.4098

Open:

$0.4426

24h Volume:

13.55M

Relative Volume:

0.47

Market Cap:

$27.80M

Revenue:

Net Income/Loss:

$-16.26M

P/E Ratio:

-0.3918

EPS:

-1.1814

Net Cash Flow:

$-13.50M

1W Performance:

+16.81%

1M Performance:

-13.48%

6M Performance:

-1.93%

1Y Performance:

-82.73%

1-Day Range:

$0.4034

$0.49

1-Week Range:

$0.351

$0.49

52-Week Range:

$0.1853

$3.1663

Intensity Therapeutics Inc Stock (INTS) Company Profile

Name

Intensity Therapeutics Inc

Sector

Healthcare (1131)

Industry

Biotechnology (632)

Phone

203-221-7381

Address

1 ENTERPRISE DRIVE, SUITE 430, SHELTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

INTS's Discussions on Twitter

Compare INTS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INTS Intensity Therapeutics Inc	0.4629	24.61M	0	-16.26M	-13.50M	-1.1814
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Intensity Therapeutics Inc Stock (INTS) Latest News

Dec 04, 2025

Intensity Therapeutics expands at-the-market offering - MSN

Dec 04, 2025

Intensity Therapeutics files for offering of up to $30 million common stockSEC filing - MarketScreener

Dec 04, 2025

Intensity Therapeutics announces two presentations at the upcoming 2025 San Antonio Breast Cancer Symposium - marketscreener.com

Dec 04, 2025

Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium - PR Newswire

Dec 04, 2025

Intensity Therapeutics expands at-the-market offering program to $30 million By Investing.com - Investing.com South Africa

Dec 04, 2025

Intensity Therapeutics Expands At-The-Market Offering - TipRanks

Dec 04, 2025

Intensity Therapeutics expands at-the-market offering program to $30 million - Investing.com

Dec 04, 2025

Intensity Therapeutics Expands ATM Offering to $30 Million - TradingView

Dec 04, 2025

Dec 03, 2025

Aug Shorts: Can Intensity Therapeutics Inc stock resist market sell offs - BỘ NỘI VỤ

Dec 03, 2025

How Intensity Therapeutics Inc. stock benefits from global expansionEarnings Recap Report & Verified Chart Pattern Signals - Newser

Dec 03, 2025

Delving into the physics of cancer, with Lew Bender - pharmaphorum

Dec 03, 2025

Dec 01, 2025

Intensity Therapeutics (INTS) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025

The time has not yet come to remove your chips from the table: Intensity Therapeutics Inc (INTS) - Setenews

Dec 01, 2025

Nov 30, 2025

Intensity Therapeutics shares plunge 30% after $4 million discounted stock offering - MSN

Nov 30, 2025

Nov 28, 2025

What analysts say about Intensity Therapeutics Inc stockSwing Trading Watchlist & Free Turn Volatility To Profit - earlytimes.in

Nov 28, 2025

Can Intensity Therapeutics Inc. stock resist sector downturnsJuly 2025 Rallies & Weekly High Momentum Picks - moha.gov.vn

Nov 28, 2025

Why Intensity Therapeutics Inc. stock appeals to analystsQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update (PR Newswire) - Aktiellt

Nov 27, 2025

Nov 26, 2025

Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - Aktiellt

Nov 26, 2025

Trading Recap: Will Intensity Therapeutics Inc. stock split attract more investorsJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - BỘ NỘI VỤ

Nov 26, 2025

MSN Money - MSN

Nov 26, 2025

Nov 24, 2025